Company profile: Healionics
1.1 - Company Overview
Company description
- Provider of synthetic vascular grafts and platform biomaterial scaffolds for dialysis patients and tissue regeneration. Offers STARgraft for reliable bloodstream access with resistance to occlusion and infection, and STAR Biomaterial with specific pore structure to enable angiogenesis and minimize foreign body response.
Products and services
- Novel Vascular Graft: Engineers a platform-based vascular graft delivering improved vascular access for dialysis patients, based on a biomaterial platform
- STAR Biomaterial: Architects a scaffold-based platform biomaterial with specific pore size and structure enabling angiogenesis and minimizing foreign body response
- STARgraft: Constructs a synthetic vascular graft delivering reliable bloodstream access for dialysis patients and resisting occlusion and infection
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Healionics
Polyplus Transfection
HQ: France
Website
- Description: Provider of innovative solutions for in vivo, in vitro and ex vivo delivery of nucleic acids for research, bioproduction and therapeutics, including transfection reagents for lentiviral (FectoVIR®-LV) and AAV production (FectoVIR®-AAV), PEIpro® for viral vector bioproduction, in vivo–jetPEI®, LipidBrick® Library for LNP formulation, and in vivo-jetRNA®+ for mRNA/saRNA delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Polyplus Transfection company profile →
ATDBio
HQ: United Kingdom
Website
- Description: Provider of specialized, large-scale DNA and RNA oligonucleotide production and innovation expertise.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ATDBio company profile →
Lunaphore
HQ: Switzerland
Website
- Description: Provider of chip-based spatial biology solutions that extract spatial proteomic and transcriptome data from tumors and other tissues, transforming any assay into multiplex spatial biology via an easy-to-use interface. Products include COMET, a fully automated high-throughput hyperplex platform integrating staining, imaging, and image preprocessing, and HORIZON, image analysis software for hyperplex immunofluorescence and cell-based analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lunaphore company profile →
LifeMine Therapeutics
HQ: United States
Website
- Description: Provider of genomics-, AI-, and synthetic biology-enabled drug discovery and development leveraging evolutionary insights from fungi. Offerings include Top-Down Drug Discovery and Avatar-Rx platforms, the LifeBank collection of 100,000 deep-sequenced wild-type fungi spanning over 25,000 species, pipeline programs such as LIFE-001 for transplantation and an anti-fungal portfolio, plus a GSK alliance to identify novel small-molecule leads for multiple disease areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LifeMine Therapeutics company profile →
Definigen
HQ: United Kingdom
Website
- Description: Provider of in-vitro liver and metabolic disease models using iPSC technology to generate pre-clinical human data, offering Opti-HEPs for drug efficacy and predictive toxicology screening, phenotypic screening with bioassays, and custom disease model development via CRISPR. Includes models for Alpha-1 Antitrypsin Deficiency, Wilson's Disease (ATP7B), and Glycogen Storage Disease Type 1 Alpha.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Definigen company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Healionics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Healionics
2.2 - Growth funds investing in similar companies to Healionics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Healionics
4.2 - Public trading comparable groups for Healionics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →